Abcam’s tissue clearing kits and reagents enable easy and rapid clearing for 3D imaging of tissues and cell culture models. Traditionally, 3D imaging of thick tissue sections and 3D cell culture models (organoids, microtissues, spheroids) has presented many technical challenges, including laborious and time-consuming tissue processing, layer-by-layer 2D imaging of thin sections and in silico […]
This author has yet to write their bio.
Meanwhile lets just say that we are proud connective contributed a whooping 138 entries.
Abcam to Develop Conjugated FFPE IHC Validated Antibodies Compatible with the GeoMx DSP Seattle and Cambridge, UK, 1 April, 2019 — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a commercial agreement with Abcam plc (AIM:ABC), a global innovator in life science reagents and […]
New Jersey, USA and Cambridge, UK – 25 March 2019: Abcam, a global innovator in life science reagents and tools, and Visikol, a contract research organisation focused on advancing drug discovery, have announced a collaboration to develop new reagents and kits for improved tissue clearing and 3D imaging. Tissue clearing methods, which are essential to […]
China represents an important market for us and we are thrilled to announce that Abcam has been chosen as the winner of the Cambridge Business Weekly UK-China Business Award. This new award category, which acknowledges the most effective ambassador for UK/China trade and trust over the last 12 months, has been jointly promoted by the […]
Cambridge, UK – 27 February 2019 : Abcam, a global innovator in life science reagents and tools, is pleased to announce its move to new state-of-the-art global headquarters, Discovery Drive, on the Cambridge Biomedical Campus (CBC), UK, a leading hub of healthcare, science and medical research. Alan Hirzel, CEO, Abcam, commented: “Abcam has been working […]
We are pleased to announce that Dr Michael Weiner, Abcam’s Vice President of Molecular Sciences, is the winner of CiteAb’s 2019 Lifetime achievement award. The award recognizes individuals who have made a significant contribution to the research reagent industry over a sustained period of time. Dr Andrew Chalmers, founder of CiteAb, said: “Dr Weiner has […]
London and Cambridge, UK, 28 January 2019: Abcam plc, a global innovator in life science reagents and tools, is pleased to announce its acquisition of Calico Biolabs, a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostics and pharmaceutical company partners. Joyce Young, Vice President of Custom Services, Abcam commented:“This acquisition strategically expands our […]
London and Cambridge, UK, 22 January 2019: Abcam plc, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation dedicated to the development of therapeutics for CDKL5 Deficiency Disorder, announced a research collaboration to discover new tools to advance research in this area of high unmet medical need. […]
Suzhou, China and Cambridge, UK, December 6: Abcam plc, a global innovator in life science reagents and tools, and QIAGEN (Suzhou) Translational Medicine Co., Ltd. (QIAGEN (Suzhou)) have signed a Memorandum of Understanding (MoU) agreement to jointly develop a pipeline of Companion Diagnostic (CDx) and In Vitro Diagnostic reagents and kits, to meet the specific […]
Award from Management Today celebrates the highest performing companies in British business. Abcam Plc, a leading provider of protein research tools and services, announced today it had been voted in at number 16 in Management Today’s “Britain’s Most Admired Companies (BMAC) 2018”, and 5th in the Health and Household sector. The BMAC Awards are an […]
© Abcam plc. all rights reserved.
Website by FisherPaul